Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
The Journal of Infectious Diseases|April 1, 1990
An outbreak of hepatitis A among cancer patients treated with interleukin-2 and lymphokine-activated killer cellsI B Weisfuse, D J Graham, M Will, et al.
Cell Death & Disease|March 24, 2017
Kaiso depletion attenuates the growth and survival of triple negative breast cancer cellsBlessing I Bassey-Archibong, Lyndsay G A Rayner, Shawn M Hercules, et al.
Cancer Research|August 1, 1988
Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humansD H Boldt, B J Mills, B T Gemlo, et al.
Journal of the National Cancer Institute|July 1, 1982
Circulating immune complex levels in patients with gestational trophoblastic neoplasiaA A Rayner, R Berkowitz, G Steele, et al.
The Journal of Hospital Infection|February 26, 2008
Mycobacteria and allograft heart valve banking: an international surveyR M Warwick, J G Magee, J P Leeming, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1991
Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721F E Halberg, S M LaRue, A A Rayner, et al.
American Journal of Medical Genetics. Part A|October 16, 2007
Posterior polymorphous corneal dystrophy is associated with TCF8 gene mutations and abdominal herniaAnthony J Aldave, Vivek S Yellore, Fei Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cellsM H Bar, M Sznol, M B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimenD R Parkinson, R I Fisher, A A Rayner, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1994
A phase II clinical trial of interleukin-2 and lymphokine-activated killer cells in advanced colorectal carcinomaM J Hawkins, M B Atkins, J P Dutcher, et al.
Pageof 30